News

As per the approval, Sinovac is required to conduct each phase of the human clinical trials in accordance with SFDA requirements, to conduct studies to assess safety and

The safety and efficacy of Rhucin for the treatment of HAE attacks were evaluated in two randomized placebo-controlled studies and are supported by four open label treatment studies.

Nuvigil is indicated to improve wakefulness in patients with excessive sleepiness associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy. In its letter to

The company expects to recruit around 120 newly-diagnosed GBM patients at treatment centers in the US and India in order to evaluate Azixa combination therapy as a first-line

The Phase 2 trial will investigate whether VT-122 in combination with Nexavar increases ‘Clinical Benefit Response,’ which is a composite measurement of pain, performance status, and lean body

With the initiation of the trial, Emergent BioSolutions has dosed first patient in the trial. According to the company, the Phase I trial is designed to investigate the

Earlier, Pain Therapeutics and King have entered into a strategic alliance to develop and commercialize Remoxy and other abuse-resistant opioid painkillers, in 2005. Remoxy, developed by Pain Therapeutics,

Glucotim LA of Centaur Pharma is an original research formulation of Timolol Long Acting developed by Senju. Centaur Pharma has introduced the vial for the first time in

As per the terms of the modification Elan will pay $9m to Transition at the time of signing the modified agreement and will also pay $11m upon the